- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation
Total 7282 results
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
University of Sao PauloCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
King's College Hospital NHS TrustUniversity of BrightonCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Imperial College Healthcare NHS TrustNational Institute for Health Research, United KingdomTerminatedChronic Obstructive Pulmonary DiseasesUnited Kingdom
-
my mhealth LtdPortsmouth Hospitals NHS TrustCompletedChronic Obstructive Pulmonary DiseasesUnited Kingdom
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Universidad de GranadaHospital de Alta Resolucion de Loja. Agencia Sanitaria Hospital de Poniente; Genyo-CentroPfizer-UGR-Junta Andalucia de genomica e investigacion oncologicaUnknownCOPD | COPD Exacerbation | COPD, Severe Early-OnsetSpain
-
my mhealth LtdPortsmouth Hospitals NHS TrustCompletedChronic Obstructive Pulmonary DiseasesUnited Kingdom
-
Beaumont HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Ireland
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
Poitiers University HospitalCompletedBroncho Chronic Obstructive Pulmonary DiseaseFrance
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Netherlands, Argentina, South Africa, Chile, Peru
-
Laval UniversityMaltais, Francois, M.D.; Saey, Didier, M.D.CompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Czechia, Hungary, Russian Federation
-
University of AarhusCompletedChronic Obstructive Pulmonary Disease ModerateDenmark
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United States, Canada, India, Italy, Poland, South Africa
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Nuvaira, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)Netherlands, South Africa
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
University Medical Center GroningenTerminatedChronic Obstructive Pulmonary Disease (COPD)Netherlands
-
University Hospital, ToursCompletedSevere Chronic Obstructive Pulmonary DiseaseFrance
-
Air Liquide Santé InternationalITEC Services; Lincoln Medical and Mental Health CenterCompletedChronic Obstructive Pulmonary Disease (COPD)France, Spain, Germany, Italy
-
Aveiro UniversityFundação para a Ciência e a TecnologiaCompletedChronic Obstructive Pulmonary Disease (COPD)Portugal
-
Universidade Federal de PernambucoConselho Nacional de Desenvolvimento Científico e TecnológicoUnknownChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Air Force Military Medical University, ChinaUnknownChronic Obstructive Pulmonary Disease (COPD)China
-
Pulmatrix Inc.Quotient ClinicalCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
University of EdinburghThe Dunhill Medical TrustCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Universidade Federal de Sao CarlosCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Helse Stavanger HFCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
Hospital de MataróCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)Denmark, Germany, Netherlands, Finland, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Spain, Canada, Slovakia, India, Netherlands, Czech Republic, Hungary
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Russian Federation, Germany, Denmark, Italy, Canada, Czech Republic, Hungary, India, Slovakia, France, Colombia, Finland, Taiwan, Iceland, Peru
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan, Korea, Republic of, Japan, India, Hong Kong, Singapore
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDChina
-
Pearl Therapeutics, Inc.CompletedCOPD, Chronic Obstructive Pulmonary DiseaseBelgium
-
Laval UniversityRecruitingOxygen Deficiency | COPD ExacerbationCanada
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, Germany, United Kingdom, China, Philippines, Italy, Chile, Taiwan, Thailand, France, Puerto Rico, Israel, Peru, Colombia, Poland, Brazil, Russian Federation, Romania, Greece
-
University of Nove de JulhoCompletedChronic Obstructive Pulmonary Disease (COPDBrazil
-
Newcastle-upon-Tyne Hospitals NHS TrustAstraZeneca; Newcastle UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
Cliniques universitaires Saint-Luc- Université...CompletedSevere Chronic Obstructive Pulmonary DiseaseBelgium
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States